A detailed history of Parkworth Wealth Management, Inc. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Parkworth Wealth Management, Inc. holds 1 shares of GH stock, worth $44. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Holding current value
$44
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$31.77 - $49.94 $31 - $49
1 New
1 $43,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.5B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Parkworth Wealth Management, Inc. Portfolio

Follow Parkworth Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkworth Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parkworth Wealth Management, Inc. with notifications on news.